Go Deep
CervoMed Inc.
CervoMed Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 23,158 | -0.7 | 1.51 | 0.00 | 217.43 |
| Oct 2026 | 23,191 | -0.7 | 1.48 | 0.00 | 213.66 |
| Oct 2026 | 23,199 | -0.7 | 1.48 | 0.00 | 212.16 |
| Oct 2026 | 23,141 | -0.7 | 1.52 | 0.00 | 219.03 |
| Oct 2026 | 23,158 | -0.7 | 1.51 | 0.00 | 217.13 |
| Oct 2026 | 23,116 | -0.7 | 1.54 | 0.00 | 221.32 |
| Oct 2026 | 23,199 | -0.7 | 1.48 | 0.00 | 211.44 |
CervoMed Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -6,571,656.0 | -7,964,158.0 | -8,087,290.0 | -7,726,639.0 |
| EPS | -0.6 | -0.9 | — | -0.8 |
CervoMed Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Net Profit | -26,966,367.0 | -16,290,695.0 | -2,171,873.0 | -5,803,047.0 | — |
| EPS | -3.0 | -2.0 | -0.8 | -11.2 | — |
CervoMed Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 22,879,018.0 | 43,081,610.0 | 9,972,521.0 | 4,157,706.0 | — |
| Total Liabilities | 4,656,117.0 | 3,879,282.0 | 2,595,747.0 | 37,442,765.0 | — |
| Total Equity | 18,222,901.0 | 39,202,328.0 | 7,376,774.0 | -33,285,059.0 | — |
Owes vs Owns
CervoMed Inc. owed $0.12 for every $1 it owned in Jun 2026, down from $9.01 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.12× | 0.20× | 0.09× | 0.26× | 9.01× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
CervoMed Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 91.2%Receivables 1.9%Other assets 6.9%
How it's funded — Dec 2025
Payables 6.4%Other liabilities 14.0%Shareholders' equity 79.6%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 20.9 | 38.9 | 7.8 | 4.1 |
| Receivables | 0.4 | 2.3 | 0.9 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.0 | 0.0 | 0.0 | 0.0 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 1.6 | 1.9 | 1.3 | 0.1 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 0.0 | 0.0 | 12.4 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Payables | 1.5 | 1.5 | 0.7 | 0.1 |
| Other liabilities | 3.2 | 2.4 | 1.9 | 24.9 |
| Shareholders' equity | 18.2 | 39.2 | 7.4 | -33.3 |
| Net tangible assets | 18.2 | 39.2 | 7.4 | -33.3 |
CervoMed Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -23,449,963.0 | -16,530,827.0 | -7,449,847.0 | -2,572,759.0 | — |
| Investing Activities | 18,097,249.0 | -28,661,129.0 | 0.0 | -12,235,738.0 | — |
| Financing Activities | 4,588,687.0 | 46,398,606.0 | 11,149,114.0 | 0.0 | — |